Literature DB >> 22865357

Hexavalent chromium and its effect on health: possible protective role of garlic (Allium sativum Linn).

Kusal K Das1, Salim A Dhundasi, Swastika N Das.   

Abstract

Hexavalent chromium or chromium (VI) is a powerful epithelial irritant and a confirmed human carcinogen. This heavy metal is toxic to many plants, aquatic animals, and bacteria. Chromium (VI) which consists of 10%-15% total chromium usage, is principally used for metal plating (H2Cr2O7), as dyes, paint pigments, and leather tanning, etc. Industrial production of chromium (II) and (III) compounds are also available but in small amounts as compared to chromium (VI). Chromium (VI) can act as an oxidant directly on the skin surface or it can be absorbed through the skin, especially if the skin surface is damaged. The prooxidative effects of chromium (VI) inhibit antioxidant enzymes and deplete intracellular glutathione in living systems and act as hematotoxic, immunotoxic, hepatotoxic, pulmonary toxic, and nephrotoxic agents. In this review, we particularly address the hexavalent chromium-induced generation of reactive oxygen species and increased lipid peroxidation in humans and animals, and the possible role of garlic (Allium sativum Linn) as a protective antioxidant.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22865357     DOI: 10.1515/jbcpp.2011.008

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  2 in total

1.  Utility of Ochrobactrum anthropi YC152 in a Microbial Fuel Cell as an Early Warning Device for Hexavalent Chromium Determination.

Authors:  Guey-Horng Wang; Chiu-Yu Cheng; Man-Hai Liu; Tzu-Yu Chen; Min-Chi Hsieh; Ying-Chien Chung
Journal:  Sensors (Basel)       Date:  2016-08-16       Impact factor: 3.576

2.  The Protective Role of Hyaluronic Acid in Cr(VI)-Induced Oxidative Damage in Corneal Epithelial Cells.

Authors:  Wei Wu; Hua Jiang; Xinnian Guo; Yu Wang; Shibo Ying; Lingfang Feng; Tao Li; Hailing Xia; Yixiao Zhang; Riping Chen; Tianhui Chen; Jianlin Lou
Journal:  J Ophthalmol       Date:  2017-03-27       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.